Cargando…

Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease

Background and aim: Managing patients with a chronic condition such as inflammatory bowel disease (IBD), requires a multidiscipline approach. The pharmacist might be the first point of contact for patients with initial symptoms or relapsing flares, yet there is no available literature on the role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Sharmila S., Keely, Simon, Talley, Nicholas J., Kairuz, Therése, Walker, Marjorie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355482/
https://www.ncbi.nlm.nih.gov/pubmed/32316504
http://dx.doi.org/10.3390/pharmacy8020068
_version_ 1783558285706657792
author Prasad, Sharmila S.
Keely, Simon
Talley, Nicholas J.
Kairuz, Therése
Walker, Marjorie M.
author_facet Prasad, Sharmila S.
Keely, Simon
Talley, Nicholas J.
Kairuz, Therése
Walker, Marjorie M.
author_sort Prasad, Sharmila S.
collection PubMed
description Background and aim: Managing patients with a chronic condition such as inflammatory bowel disease (IBD), requires a multidiscipline approach. The pharmacist might be the first point of contact for patients with initial symptoms or relapsing flares, yet there is no available literature on the role of pharmacists in IBD management. We conducted a survey to explore pharmacists’ confidence in and potential barriers to managing IBD and assess the impact of IBD education on their confidence in IBD management. Methods: Surveys assessing confidence levels in managing IBD, additional learning opportunities about IBD and barriers to their learning of IBD management were provided to pharmacists for completion before and after attending an IBD-specific education session at a national conference. Results: Of the 195 attendees, 125 participants completed the survey (64%). Most respondents reported a low to mid-range level of confidence with managing IBD. Specifically, they were only slightly confident in decision making on patient care, addressing patient needs and providing additional support for IBD patients; and somewhat confident with understanding, management and providing relevant information on IBD. Whist the education session improved pharmacists perceived level of confidence, most respondents indicated a need to learn more about IBD. Areas of additional learning included science, drug therapy, treatments (includes non-pharmacological options as well) and guidelines. A majority of pharmacists identified time constraints as a key barrier to learning. Conclusion: Pharmacists lack sufficient confidence about managing inflammatory bowel disease. These data indicate support within the pharmacy profession to play a more active role in the management of IBD.
format Online
Article
Text
id pubmed-7355482
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73554822020-07-23 Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease Prasad, Sharmila S. Keely, Simon Talley, Nicholas J. Kairuz, Therése Walker, Marjorie M. Pharmacy (Basel) Article Background and aim: Managing patients with a chronic condition such as inflammatory bowel disease (IBD), requires a multidiscipline approach. The pharmacist might be the first point of contact for patients with initial symptoms or relapsing flares, yet there is no available literature on the role of pharmacists in IBD management. We conducted a survey to explore pharmacists’ confidence in and potential barriers to managing IBD and assess the impact of IBD education on their confidence in IBD management. Methods: Surveys assessing confidence levels in managing IBD, additional learning opportunities about IBD and barriers to their learning of IBD management were provided to pharmacists for completion before and after attending an IBD-specific education session at a national conference. Results: Of the 195 attendees, 125 participants completed the survey (64%). Most respondents reported a low to mid-range level of confidence with managing IBD. Specifically, they were only slightly confident in decision making on patient care, addressing patient needs and providing additional support for IBD patients; and somewhat confident with understanding, management and providing relevant information on IBD. Whist the education session improved pharmacists perceived level of confidence, most respondents indicated a need to learn more about IBD. Areas of additional learning included science, drug therapy, treatments (includes non-pharmacological options as well) and guidelines. A majority of pharmacists identified time constraints as a key barrier to learning. Conclusion: Pharmacists lack sufficient confidence about managing inflammatory bowel disease. These data indicate support within the pharmacy profession to play a more active role in the management of IBD. MDPI 2020-04-17 /pmc/articles/PMC7355482/ /pubmed/32316504 http://dx.doi.org/10.3390/pharmacy8020068 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Prasad, Sharmila S.
Keely, Simon
Talley, Nicholas J.
Kairuz, Therése
Walker, Marjorie M.
Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease
title Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease
title_full Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease
title_fullStr Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease
title_full_unstemmed Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease
title_short Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease
title_sort pharmacists’ confidence in managing patients with inflammatory bowel disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355482/
https://www.ncbi.nlm.nih.gov/pubmed/32316504
http://dx.doi.org/10.3390/pharmacy8020068
work_keys_str_mv AT prasadsharmilas pharmacistsconfidenceinmanagingpatientswithinflammatoryboweldisease
AT keelysimon pharmacistsconfidenceinmanagingpatientswithinflammatoryboweldisease
AT talleynicholasj pharmacistsconfidenceinmanagingpatientswithinflammatoryboweldisease
AT kairuztherese pharmacistsconfidenceinmanagingpatientswithinflammatoryboweldisease
AT walkermarjoriem pharmacistsconfidenceinmanagingpatientswithinflammatoryboweldisease